A Randomized Study to Evaluate Pharmacodynamics, Pharmacokinetics, Safety and Tolerability of Transitioning From Alendronate to a Single Subcutaneous Dose of AMG 785 in Postmenopausal Women with Low Bone Mass

Sponsor ID

20060223

Clinicaltrials.gov ID

EUCTIS ID

N/A

EudraCT ID

N/A

Study Details

Phase

N/A

Product

AMG 785

Type

Interventional

Masking

N/A

Enrollment

N/A

Additional Study Details

Primary Outcome Measures

Not Available

Secondary Outcome Measures

Not Available

Study Synopsis

Available Language(s): English

No locations found.